You are here
P&T September 2014
A malpractice claims analysis by an insurer, Healthcare Providers Service Organization, provides recommendations for avoiding errors and injuries. Case examples relate these suggestions to situations that are common in health care settings.
Provisions in the Patient Protection and Affordable Care Act aim to reduce hospital admissions—and, by extension, hospital revenue. In some cases, the emphasis on bundled payments and other initiatives is speeding consolidations and closures.
Schizophrenia is a complex disorder characterized by an array of symptoms. This heterogeneity has resulted in a lack of consensus regarding diagnostic criteria, etiology, and pathophysiology, and has complicated efforts to devise effective treatments.
New medications may soon offer more effective treatments for the approximately 2.5 million patients globally with schizophrenia. Current therapies in 2012 yielded $5.2 billion in global market sales, but by 2022 that is expected to reach $7.9 billion.
We often abandon the “second victims” of medical errors
In a new 340B controversy, OPA rebuffs a court ruling
FDA approvals, drug indications, and updates
Belinostat (Beleodaq) for peripheral T-cell lymphoma; C1-esterase inhibitor (Ruconest) for acute attacks in hereditary angioedema; and tedizolid phosphate (Sivextro) for acute bacterial skin and skin structure infections
Loxapine inhalation powder (Adasuve): an innovative formulation of an antipsychotic treatment for agitation